Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
neuromuscular blocking agent |
| gptkbp:approvedBy |
1995
|
| gptkbp:ATCCode |
M03AC11
|
| gptkbp:brand |
Nimbex
|
| gptkbp:CASNumber |
96946-42-8
|
| gptkbp:chemicalFormula |
C53H72N2O12
|
| gptkbp:contraindication |
hypersensitivity to cisatracurium
|
| gptkbp:developedBy |
gptkb:Glaxo_Wellcome
|
| gptkbp:eliminationHalfLife |
22 to 29 minutes
|
| https://www.w3.org/2000/01/rdf-schema#label |
cisatracurium
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
blocks acetylcholine at neuromuscular junction
|
| gptkbp:metabolism |
gptkb:Hofmann_elimination
|
| gptkbp:molecularWeight |
929.16 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
CHEMBL1201192
6918284 |
| gptkbp:relatedTo |
gptkb:atracurium
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
hypotension
flushing bronchospasm |
| gptkbp:UNII |
5C0H1793PG
|
| gptkbp:usedFor |
facilitation of endotracheal intubation
muscle relaxation during surgery |
| gptkbp:bfsParent |
gptkb:peripheral_muscle_relaxants
|
| gptkbp:bfsLayer |
8
|